Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Drugs Single-chain-MHC-complexes-and-uses-thereof

 Chemical and/or biological decontamination system
OF THE INVENTION The present invention provides a composition that is effective in the ...


 Immunostimulant bacterial membrane fractions in cancer treatment
The invention claimed is: 1. A method of stimulating an immune response and/or inducing an ...


 Cloning and characterization of a human adenylyl cyclase
One aspect of the invention is an isolated and purified human type VI adenylyl cyclase (hAC6) ...


 Tumor antigen based on products of the tumor suppressor gene WT1
What is claimed is: 1. An isolated polypeptide which consists of at most 12 contiguous amino acid ...


 Methods of inhibiting GPR-9-6 function
The invention relates to an antibody (immunoglobulin) or functional fragment thereof (e.g., an ...


 Method for cloning of a rare, specifically mutated cell
The invention is a new and improved method for reliably detecting the presence of a rare cell ...


 Vaccine against Gram-negative bacterial infections
OF THE PREFERRED EMBODIMENTS According to the present invention, a non-covalent, polyvalent ...


 Modified human hemoglobin, blood substitutes containing the same, and vectors for expressing the modified hemoglobin
The present invention relates to modified .beta.-chains of human hemoglobin having an oxygen ...


 Inhibitor of stem cell proliferation and uses thereof
The present invention relates to polypeptides which are inhibitors of stem cell proliferation ("INPR...


 Inhibitor of stem cell proliferation and uses thereof
The present invention relates to an inhibitor of stem cell proliferation (INPROL) characterized by ...


 Single chain MHC complexes and uses thereof

Details
Inventors: Rhode, Peter R.; Jiao, Jin-An; Burkhardt, Martin; Wong, Hing C.;
Assignee: Sunol Molecular Corporation (Miami, FL)
Primary Examiner: Walsh; Stephen
Assistant Examiner: Brown; Karen E.
Attorney, Agent or Firm: Corless; Peter F., Buchanan; Robert L. Dike, Bronstein, Roberts & Cushman, LLP

The present invention relates to novel complexes of major histocompatibility complex (MHC) molecules and uses of such complexes. In one aspect, the invention relates to loaded MHC complexes that include at least one MHC molecule with a peptide-binding groove and a presenting peptide non-covalently linked to the MHC protein. In another aspect, the invention features single chain MHC class II peptide fusion complexes with a presenting peptide covalently linked to the peptide binding grove of the complex. MHC complexes of the invention are useful for a variety of applications including: 1) in vitro screens for identification and isolation of peptides that modulate activity of selected T cells, including peptides that are T cell receptor antagonists and partial agonists, and 2) methods for suppressing or inducing an immune response in a mammal.

DETAILED DESCRIPTION The present invention relates to novel complexes of major histocompability complex (MHC) molecules (class I or II), e.
g.
, empty single chain MHC class II complexes, loaded single chain MHC class II complexes, and single chain MHC class II peptide fusion complexes and the uses of such MHC complexes.
We have now discovered that single chain MHC class complexes without a covalently linked presenting peptide (i.
e.
an empty MHC complex) can be loaded by contacting a presenting peptide to the complex so that the presenting peptide non-covalently binds to the peptide binding groove of the complex.
Generally, the presenting peptide will non-covalently bind to the peptide binding groove of the empty MHC complex via stable hydrogen bonding.
The single chain MHC class complexes of the present invention, particularly single chain MHC class II complexes, are surprisingly stable and are useful in a variety of applications.
For example, loaded single chain MHC class II complexes or single chain MHC class II peptide fusion complexes can be used to modulate various immune system responses in a mammal, e.
g.
, T cell apoptosis, T cell anergy, T cell cytokine release, immunosuppression and induction of T cells.
Empty MHC molecules, particularly empty single chain MHC class II molecules, are useful in, e.
g.
, in vitro screens for detecting peptides that modulate the activity of T cells, including peptides which are T cell receptor antagonists and partial agonists.
We previously disclosed highly useful MHC class I and class II peptide fusion molecules in unpublished PCT Application No.
PCT/US95/09816, filed Jul.
31, 1995 (sometimes referred to herein as said "PCT Application") as well as pending U.
S.
application Ser.
No.
08/382,454, filed Feb.
1, 1995.
The MHC fusion complexes comprise a presenting peptide covalently linked (i.
e.
fused) to the MHC molecule.
The PCT Application No.
PCT/US95/09816 and said U.
S.
application Ser.
No.
08/382,454 are herein incorporated by reference in its entirety



Related patents
  IL-1/TNF-.alpha.-activated kinase (ITAK), and methods of making and using the same
The present invention provides nucleic acid and amino acid sequences of protein kinases, preferably human, that interact with at least one post-receptor intracellular ...
  DNA encoding IL-1 receptor accessory protein
What is claimed is: 1. An isolated polynucleotide comprising SEQ ID NO:1 wherein the nucleic acid at 1792 is A or C. 2. An isolated polynucleotide comprising a nucleic ...
  Human immunodeficiency virus immunogenic composition
The present invention relates to an HLA-based vaccine against HIV. Vaccines of the invention, which induce salutary anti-HIV immune responses, can be designed based on ...
  Recombinant molecule encoding human protease nexin
We claim: 1. An isolated DNA molecule which encodes mature protease nexin-I (PN-I) alpha of FIG. 3 or PN-I beta of FIG. 4 or encodes a PN-I protein encoded by a gene ...
  Method for design of substances that enhance memory and improve the quality of life
I claim: 1. Each of the compounds Gln Phe Phe-.gamma.-aminobutyric acid (SEQ ID NO: 20) Gln Phe Phe-.beta.-alanine (SEQ ID NO: 21) Gln Phe Phe-.delta.-aminovaleric acid (...
  Amyloid .beta. protein (globular assembly and uses thereof)
What is claimed is: 1. An isolated, soluble, non-fibrillar amyloid .beta. protein assembly comprising 3-12 amyloid .beta. proteins, wherein the amyloid .beta. protein is ...
  Chlamydia antigens and corresponding DNA fragments and uses thereof
The present invention provides purified and isolated polynucleotide molecules that encode the Chlamydia polypeptide designated 76 kDa protein (SEQ ID No: 1) which can be ...
  Methods of treating inflammatory bowel disease using cholera toxin B subunit
What is claimed is: 1. A method of treating inflammatory bowel disease in a subject diagnosed with inflammatory bowel disease, comprising administering to the subject a ...
  Mammalian haemoglobin compatible with blood plasma, cross-linked and conjugated with polyalkylene oxides as artificial medical oxygen carriers, production and use thereof
1. Hemoglobin derivative compatible with human and non-human animal plasma, comprising hemoglobin crosslinked by means of a crosslinker for proteins and a polyalkylene ...
  Anti hepatitis C virus antibody and uses thereof
OF THE PRESENT INVENTION Accordingly, the technical problem of the invention is to provide means and methods for the treatment and prevention of HCV infection in humans....

0.004

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved